Page last updated: 2024-10-22

amlodipine and Parkinson Disease, Secondary

amlodipine has been researched along with Parkinson Disease, Secondary in 2 studies

Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaur, U1
Das, P1
Gambhir, IS1
Chakrabarti, SS1
Sempere, AP1
Duarte, J1
Cabezas, C1
Coria, F1
Clavería, LE1

Other Studies

2 other studies available for amlodipine and Parkinson Disease, Secondary

ArticleYear
L-type calcium channel blockers and a symptom complex mimicking de Melo-Souza's syndrome.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2019, Volume: 40, Issue:5

    Topics: Aged; Amlodipine; Calcium Channel Blockers; Calcium Channels, L-Type; Diagnosis, Differential; Femal

2019
Parkinsonism induced by amlodipine.
    Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:1

    Topics: Aged; Amlodipine; Female; Follow-Up Studies; Humans; Hypertension; Parkinson Disease, Secondary

1995